Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free OLMA Stock Alerts

Olema Pharmaceuticals (OLMA) SEC Filings & 10K Form

Olema Pharmaceuticals logo
$6.10 +0.31 (+5.35%)
(As of 12/20/2024 05:45 PM ET)
Compare

Recent Olema Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
12/18/2024
5:52 PM		Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4/A
12/17/2024
6:52 PM		Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
6:29 PM		Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:37 PM		Logos Opportunities Fund I LP (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:56 PM		Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:56 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:52 PM		Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:53 PM		Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:54 PM		Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:19 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
4:04 PM		Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:27 PM		Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:30 PM		Bain Capital Life Sciences Opportunities IV, L.P. (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13G
12/11/2024
3:33 PM		Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
2:23 PM		Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
1:48 PM		Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
1:14 PM		Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
1:21 PM		Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
1:38 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
6:15 AM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
6:15 AM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:48 PM		Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4/A
11/18/2024
5:00 AM		Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:34 PM		Olema Pharmaceuticals (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SC 13G/A
11/14/2024
8:20 AM		Deep Track Capital, LP (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13G/A
09/27/2024
6:00 AM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:15 PM		Olema Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
4:15 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:23 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
4:15 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
11:59 AM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:30 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:30 PM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
2:13 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
4:31 PM		BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:39 PM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:34 PM		Olema Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
06/06/2024
5:49 PM		Logos Global Management LP (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13D/A
06/06/2024
9:02 AM		Logos Opportunities Fund I LP (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
9:05 AM		Logos Opportunities Fund II LP (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW
06/04/2024
8:00 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:09 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
1:55 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
11:17 AM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
6:06 AM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:15 PM		Olema Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
4:00 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:00 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
2:25 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/26/2024
4:10 PM		Olema Pharmaceuticals (Filer)
Form DEFA14A
04/26/2024
4:15 PM		Olema Pharmaceuticals (Filer)
Form ARS
03/29/2024
4:00 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
10:02 AM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
3:31 PM		Deep Track Capital, LP (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13G
03/20/2024
4:30 PM		Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:31 PM		Olema Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2024
3:15 PM		Olema Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:36 PM		Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:30 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
1:26 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
11:53 AM		Kynam Capital Management, LP (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
4:16 PM		Olema Pharmaceuticals (Filer)
Form 424B3
02/12/2024
11:21 AM		JANUS HENDERSON GROUP PLC (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2024
11:15 PM		Olema Pharmaceuticals (Filer)
Form EFFECT
02/05/2024
4:30 PM		Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:30 PM		Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:30 PM		Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:30 PM		Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:00 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
2:24 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
1:58 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
4:25 PM		BlackRock Inc. (Filed by)
Olema Pharmaceuticals (Subject)
Form SC 13G
01/29/2024
6:30 AM		Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:30 AM		Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:07 AM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:18 AM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:25 PM		Olema Pharmaceuticals (Filer)
Form 424B5
01/05/2024
4:26 PM		Olema Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
4:30 PM		Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:OLMA) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...
Banyan Hill Publishing | Sponsored
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...
Behind the Markets | Sponsored
Rare "crisis signal" triggers for third time in U.S. market
A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...
Stansberry Research | Sponsored
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...
Brownstone Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Altcoin season moves fast, and those who hesitate are left behind. The window is closing.
Crypto Swap Profits | Sponsored
HOTTEST TRADER IN AMERICA 🔥🔥🔥
Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...
Timothy Sykes | Sponsored
Buffett's Oil Bet + This 22% Dividend Play
Warren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...
Investors Alley | Sponsored
Buy this coin BEFORE Inauguration Day …
Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...
Weiss Ratings | Sponsored